Green Cross Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 3,890.00
0.00 (0.00%)
At close: May 4, 2026
KOSDAQ:142280 Market Cap
KOSDAQ:142280 has a market cap or net worth of 84.58 billion as of May 5, 2026. Its market cap has increased by 12.94% in one year.
Market Cap
84.58B
Enterprise Value
103.66B
Revenue
108.41B
Ranking
n/a
PE Ratio
26.64
Stock Price
3,890.00
Market Cap Chart
Since December 17, 2014, KOSDAQ:142280's market cap has decreased from 98.95B to 84.58B, a decrease of -14.52%. That is a compound annual growth rate of -1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 84.58B | -2.87% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 455.23B |
| 3billion | 429.10B |
| Inventera | 167.93B |
| GENINUS | 165.84B |
| Cytogen | 136.11B |
| HLB Panagene | 96.63B |
| Protia | 64.51B |
| Seoulin Bioscience | 55.96B |